Loading, please wait ...


News Analytics

healio safe image.
Fortunately, in the last few years, there are drugs looking to stop the itch cascade.” The phase 3 ECZTRA 3 study included 380 patients with atopic dermatitis randomly assigned 2:1 to receive subcutaneous tralokinumab 300 mg (Leo Pharma) every 2 weeks plus topical corticosteroids as needed or placebo every 2 weeks plus topical corticosteroids as needed for 16 weeks.
Google

Subject Matter

  • Healthcare 100.00%
    • Hospitals, doctors and medical care 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions